Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The metaxin 3 pseudogene is a genomic sequence related to the functional metaxin 3 gene but has acquired mutations or deletions that prevent it from producing a functional protein[1][3]. It is highly homologous to the metaxin 3 gene, containing a similar sequence, but lacks the promoter and is not actively expressed[1]. Pseudogenes, such as the metaxin 3 pseudogene, are evolutionary remnants and generally do not participate in biological pathways or disease processes unless they acquire a function—something not substantiated for this locus[3]. There is no evidence that it is involved in transport, signaling, protein production, or any disease, nor is it a target for drug development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metaxin 3 pseudogene.